Fig. 7: Acoustic aggregation of GVs@YB1 improves the anti-tumour efficacy.
From: In-vivo programmable acoustic manipulation of genetically engineered bacteria
a Schematic illustration of acoustic aggregation of GVs@YB1 to inhibit tumour growth in tumour-bearing mice. b Tumour growth curves of tumour-bearing mice in different treatment groups. c Body weight change curve of tumour-bearing mice in different treatment groups. d Survival curves for different treatment groups. e Representative photos of tumour growth in each group of tumour-bearing mice after different treatments. Data in (b, c) are presented as mean ± s.d., and n = 5 biologically independent samples per group. Statistical analysis was implemented by using the two-way analysis of variance with Tukey’s test. **** means P < 0.0001. Source data are provided as a Source Data file.
